Skip to main content

Post-IPO Equity Pharmaceutical Companies

Explore 203 pharmaceutical startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
203
Total Funding
$111.0M
Avg Funding
$37.0M
Cities
3

Export 203 Post-IPO Equity Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Framingham, United States
$4.5M
raised

Xenetic Biosciences is a biopharmaceutical company that provides drugs, cancer therapies, and vaccines.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ashburn, United States
$104.5M
raised

Quoin Pharmaceuticals is into developing products which address major unmet medical needs.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$2.0M
raised

Aptorum Group is a pharmaceutical company dedicated to the development of therapeutic assets to treat diseases with unmet medical needs.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 201 to 203 of 203 companies

Ready to Connect with Post-IPO Equity Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 203 post-ipo equity pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

203 Pharmaceutical Post-IPO Equity Startups (September 2026) — Page 9 | VCBacked